MDMA Pharmacology

Introduction Over the past several years, MDMA (also known as Ecstasy/Molly) has been making waves in the realms of drug research and therapy, with many efforts having been largely spearheaded by MAPS. Recognized for its ability to enhance feelings of empathy and bonding among users, research has largely aimed at examining MDMA’s therapeutic potential for […]

MDMA Pharmacology Read More »

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial

Objective The Center for Psychedelic and Consciousness Research at Johns Hopkins Medical school in Baltimore conducted a randomized, controlled clinical trial to examine if one or two administrations of psilocybin, in addition to psychological support, could be an effective treatment for patients suffering from major depressive disorder (MDD).  What is Major Depressive disorder? Major depressive

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial Read More »

Inclusion of People of Color in Psychedelic-Assisted Psychotherapy: A Review of The Literature

Are people of colour included in psychedelic research? In their paper “Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature” Michaels et al. (2018) reviewed studies on psychedelic-assisted psychotherapy published between 1993 and 2017 across countries to examine rates of inclusion for people of colour. Below we have summarized the key

Inclusion of People of Color in Psychedelic-Assisted Psychotherapy: A Review of The Literature Read More »

Why Learn How to Read Scientific Papers?

In Kyle Shannon’s Towards Data Science’s article, “A Guide to Reading Academic Research”, Shannon emphasizes that reading scientific papers is not just for gathering the right information for a good grade or bragging rights. “Reading papers certainly builds character”, he suggests.  From researcher, to child, to performance athlete, we all have experience in building character

Why Learn How to Read Scientific Papers? Read More »

Examining the Psychedelic Renaissance Season 2 – Episode 15 – Psilocybin Mushrooms vs. Psilocybin: The Dialectic Between Nature vs. Synthetic

In the season finale of Examining the Psychedelic Renaissance, join Paul Stamets for a discussion on the history of psilocybin and our knowledge of its medicinal value. Psilocybin mushrooms serve a societal need that remains unaddressed by conventional medicine. Paul champions the therapeutic benefits of psilocybin and will outline why, due to the COVID-19 outbreak,

Examining the Psychedelic Renaissance Season 2 – Episode 15 – Psilocybin Mushrooms vs. Psilocybin: The Dialectic Between Nature vs. Synthetic Read More »

Examining the Psychedelic Renaissance Season 2 – Episode 13 – Psilocybin Assisted Psychotherapy

In episode 13 of Examining the Psychedelic Renaissance, Spencer Hawkswell, CEO of TheraPsil, will discuss psilocybin-assisted therapy and its future potential. Date: Tuesday, December 15th Time: 5:00 PM – 6:30 PM PST (8:00 PM – 9:30 PM EST) About Spencer Hawkswell Spencer Hawkswell is the CEO at TheraPsil, an organization which advocates for the clinical application

Examining the Psychedelic Renaissance Season 2 – Episode 13 – Psilocybin Assisted Psychotherapy Read More »